{"id":935,"date":"2025-05-26T14:15:34","date_gmt":"2025-05-26T12:15:34","guid":{"rendered":"https:\/\/drtalk.it\/oncology\/?p=935"},"modified":"2025-05-27T11:40:57","modified_gmt":"2025-05-27T09:40:57","slug":"adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr","status":"publish","type":"post","link":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/","title":{"rendered":"ADC: gestione degli effetti collaterali nel TNBC e mBC HR+ | Matteo Lambertini incontra Angela Toss"},"content":{"rendered":"<div class=\"wpb-content-wrapper\" id=\"wpb-content-root\"><p>[vc_row][vc_column][vc_column_text css=&#8221;&#8221;]<\/p>\r\n<p class=\"has-medium-font-size\">Ospite di Matteo Lambertini (Professore Associato \u2013 Universit\u00e0 di Genova, UO Oncologia Medica \u2013 Policlinico San Martino IRCCS per l\u2019Oncologia) in questa puntata del podcast \u201cADC Talks: otto dialoghi sul mBC\u201d \u00e8 Angela Toss (Professore Associato \u2013 Universit\u00e0 degli Studi di Modena e Reggio Emilia UNIMORE, Unit\u00e0 Complessa di Oncologia AOU di Modena).<br \/>Il tema \u00e8 la gestione degli effetti collaterali del trattamento con Antibody-Drug Conjugates di TNBC e mBC HR+.<br \/>Quali profili di tollerabilit\u00e0 per i diversi ADC?<br \/>Quali sono i protocolli di gestione e qual \u00e8 l\u2019importanza di un dosaggio corretto?<\/p>\r\n<p>&nbsp;<\/p>\r\n\r\n<div style=\"margin: 2.5em auto;\"><iframe loading=\"lazy\" src=\"https:\/\/player.simplecast.com\/d7cb69a0-e3fe-44a8-8a56-013bbfd16a5d?dark=false\" width=\"100%\" height=\"200px\" frameborder=\"no\" scrolling=\"no\" seamless=\"\"><\/iframe><\/div>\r\n<p>\u00a0<\/p>\r\n\r\n<figure class=\"wp-block-audio\"><audio src=\"https:\/\/cdn.simplecast.com\/audio\/73964c44-81bc-44fb-aa50-49cb662ba5ee\/episodes\/d7cb69a0-e3fe-44a8-8a56-013bbfd16a5d\/audio\/f1679af0-93c3-4f8b-8351-c71ce3eb4951\/default_tc.mp3\" controls=\"controls\"><\/audio><\/figure>\r\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p><\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text css=&#8221;&#8221;] Ospite di Matteo Lambertini (Professore Associato \u2013 Universit\u00e0 di Genova, UO Oncologia Medica \u2013 Policlinico San Martino IRCCS per l\u2019Oncologia) in questa puntata del podcast \u201cADC Talks: otto dialoghi sul mBC\u201d \u00e8 Angela Toss (Professore Associato \u2013 Universit\u00e0 degli Studi di Modena e Reggio Emilia UNIMORE, Unit\u00e0 Complessa [&#8230;]<\/p>\n","protected":false},"author":4,"featured_media":946,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"audio","meta":{"_acf_changed":false,"footnotes":""},"categories":[173],"tags":[],"qtserie":[172],"class_list":["post-935","post","type-post","status-publish","format-audio","has-post-thumbnail","hentry","category-adc-talks","post_format-post-format-audio","qtserie-adc-talks-otto-dialoghi-sul-mbc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ADC: gestione degli effetti collaterali nel TNBC e mBC HR+ | Matteo Lambertini incontra Angela Toss - DrTalk Oncology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADC: gestione degli effetti collaterali nel TNBC e mBC HR+ | Matteo Lambertini incontra Angela Toss - DrTalk Oncology\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_column_text css=&#8221;&#8221;] Ospite di Matteo Lambertini (Professore Associato \u2013 Universit\u00e0 di Genova, UO Oncologia Medica \u2013 Policlinico San Martino IRCCS per l\u2019Oncologia) in questa puntata del podcast \u201cADC Talks: otto dialoghi sul mBC\u201d \u00e8 Angela Toss (Professore Associato \u2013 Universit\u00e0 degli Studi di Modena e Reggio Emilia UNIMORE, Unit\u00e0 Complessa [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/\" \/>\n<meta property=\"og:site_name\" content=\"DrTalk Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-26T12:15:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-27T09:40:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/drtalk.it\/oncology\/wp-content\/uploads\/sites\/2\/2025\/05\/03_OK_OK_v3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"899\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"drtalk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@drtalk_it\" \/>\n<meta name=\"twitter:site\" content=\"@drtalk_it\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"drtalk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\\\/\"},\"author\":{\"name\":\"drtalk\",\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/#\\\/schema\\\/person\\\/5b86a50683d6ad825b638ace6dc0a995\"},\"headline\":\"ADC: gestione degli effetti collaterali nel TNBC e mBC HR+ | Matteo Lambertini incontra Angela Toss\",\"datePublished\":\"2025-05-26T12:15:34+00:00\",\"dateModified\":\"2025-05-27T09:40:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\\\/\"},\"wordCount\":120,\"publisher\":{\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/05\\\/03_OK_OK_v3.png\",\"articleSection\":[\"ADC Talks\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\\\/\",\"url\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\\\/\",\"name\":\"ADC: gestione degli effetti collaterali nel TNBC e mBC HR+ | Matteo Lambertini incontra Angela Toss - DrTalk Oncology\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/05\\\/03_OK_OK_v3.png\",\"datePublished\":\"2025-05-26T12:15:34+00:00\",\"dateModified\":\"2025-05-27T09:40:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/drtalk.it\\\/oncology\\\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\\\/#primaryimage\",\"url\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/05\\\/03_OK_OK_v3.png\",\"contentUrl\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/05\\\/03_OK_OK_v3.png\",\"width\":1600,\"height\":899},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ADC: gestione degli effetti collaterali nel TNBC e mBC HR+ | Matteo Lambertini incontra Angela Toss\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/#website\",\"url\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/\",\"name\":\"DrTalk Oncology\",\"description\":\"I podcast del Pensiero Scientifico Editore\",\"publisher\":{\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/#organization\",\"name\":\"drtalk oncology\",\"url\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2020\\\/05\\\/drTalkOnco_b.png\",\"contentUrl\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2020\\\/05\\\/drTalkOnco_b.png\",\"width\":137,\"height\":95,\"caption\":\"drtalk oncology\"},\"image\":{\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/drtalk_it\",\"https:\\\/\\\/www.instagram.com\\\/drtalk_it\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCeWuPIq1vjUPniiWEI7I9Xg\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/drtalk.it\\\/oncology\\\/#\\\/schema\\\/person\\\/5b86a50683d6ad825b638ace6dc0a995\",\"name\":\"drtalk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a7927ea0ee247d1c55a4e99197004197ff3e16d67c762eb77505227a137a737f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a7927ea0ee247d1c55a4e99197004197ff3e16d67c762eb77505227a137a737f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a7927ea0ee247d1c55a4e99197004197ff3e16d67c762eb77505227a137a737f?s=96&d=mm&r=g\",\"caption\":\"drtalk\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADC: gestione degli effetti collaterali nel TNBC e mBC HR+ | Matteo Lambertini incontra Angela Toss - DrTalk Oncology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/","og_locale":"it_IT","og_type":"article","og_title":"ADC: gestione degli effetti collaterali nel TNBC e mBC HR+ | Matteo Lambertini incontra Angela Toss - DrTalk Oncology","og_description":"[vc_row][vc_column][vc_column_text css=&#8221;&#8221;] Ospite di Matteo Lambertini (Professore Associato \u2013 Universit\u00e0 di Genova, UO Oncologia Medica \u2013 Policlinico San Martino IRCCS per l\u2019Oncologia) in questa puntata del podcast \u201cADC Talks: otto dialoghi sul mBC\u201d \u00e8 Angela Toss (Professore Associato \u2013 Universit\u00e0 degli Studi di Modena e Reggio Emilia UNIMORE, Unit\u00e0 Complessa [...]","og_url":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/","og_site_name":"DrTalk Oncology","article_published_time":"2025-05-26T12:15:34+00:00","article_modified_time":"2025-05-27T09:40:57+00:00","og_image":[{"width":1600,"height":899,"url":"https:\/\/drtalk.it\/oncology\/wp-content\/uploads\/sites\/2\/2025\/05\/03_OK_OK_v3.png","type":"image\/png"}],"author":"drtalk","twitter_card":"summary_large_image","twitter_creator":"@drtalk_it","twitter_site":"@drtalk_it","twitter_misc":{"Scritto da":"drtalk","Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/#article","isPartOf":{"@id":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/"},"author":{"name":"drtalk","@id":"https:\/\/drtalk.it\/oncology\/#\/schema\/person\/5b86a50683d6ad825b638ace6dc0a995"},"headline":"ADC: gestione degli effetti collaterali nel TNBC e mBC HR+ | Matteo Lambertini incontra Angela Toss","datePublished":"2025-05-26T12:15:34+00:00","dateModified":"2025-05-27T09:40:57+00:00","mainEntityOfPage":{"@id":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/"},"wordCount":120,"publisher":{"@id":"https:\/\/drtalk.it\/oncology\/#organization"},"image":{"@id":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/#primaryimage"},"thumbnailUrl":"https:\/\/drtalk.it\/oncology\/wp-content\/uploads\/sites\/2\/2025\/05\/03_OK_OK_v3.png","articleSection":["ADC Talks"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/","url":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/","name":"ADC: gestione degli effetti collaterali nel TNBC e mBC HR+ | Matteo Lambertini incontra Angela Toss - DrTalk Oncology","isPartOf":{"@id":"https:\/\/drtalk.it\/oncology\/#website"},"primaryImageOfPage":{"@id":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/#primaryimage"},"image":{"@id":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/#primaryimage"},"thumbnailUrl":"https:\/\/drtalk.it\/oncology\/wp-content\/uploads\/sites\/2\/2025\/05\/03_OK_OK_v3.png","datePublished":"2025-05-26T12:15:34+00:00","dateModified":"2025-05-27T09:40:57+00:00","breadcrumb":{"@id":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/#primaryimage","url":"https:\/\/drtalk.it\/oncology\/wp-content\/uploads\/sites\/2\/2025\/05\/03_OK_OK_v3.png","contentUrl":"https:\/\/drtalk.it\/oncology\/wp-content\/uploads\/sites\/2\/2025\/05\/03_OK_OK_v3.png","width":1600,"height":899},{"@type":"BreadcrumbList","@id":"https:\/\/drtalk.it\/oncology\/adc-gestione-degli-effetti-collaterali-nel-tnbc-e-mbc-hr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/drtalk.it\/oncology\/"},{"@type":"ListItem","position":2,"name":"ADC: gestione degli effetti collaterali nel TNBC e mBC HR+ | Matteo Lambertini incontra Angela Toss"}]},{"@type":"WebSite","@id":"https:\/\/drtalk.it\/oncology\/#website","url":"https:\/\/drtalk.it\/oncology\/","name":"DrTalk Oncology","description":"I podcast del Pensiero Scientifico Editore","publisher":{"@id":"https:\/\/drtalk.it\/oncology\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/drtalk.it\/oncology\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/drtalk.it\/oncology\/#organization","name":"drtalk oncology","url":"https:\/\/drtalk.it\/oncology\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/drtalk.it\/oncology\/#\/schema\/logo\/image\/","url":"https:\/\/drtalk.it\/oncology\/wp-content\/uploads\/sites\/2\/2020\/05\/drTalkOnco_b.png","contentUrl":"https:\/\/drtalk.it\/oncology\/wp-content\/uploads\/sites\/2\/2020\/05\/drTalkOnco_b.png","width":137,"height":95,"caption":"drtalk oncology"},"image":{"@id":"https:\/\/drtalk.it\/oncology\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/drtalk_it","https:\/\/www.instagram.com\/drtalk_it\/","https:\/\/www.youtube.com\/channel\/UCeWuPIq1vjUPniiWEI7I9Xg\/"]},{"@type":"Person","@id":"https:\/\/drtalk.it\/oncology\/#\/schema\/person\/5b86a50683d6ad825b638ace6dc0a995","name":"drtalk","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/a7927ea0ee247d1c55a4e99197004197ff3e16d67c762eb77505227a137a737f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a7927ea0ee247d1c55a4e99197004197ff3e16d67c762eb77505227a137a737f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a7927ea0ee247d1c55a4e99197004197ff3e16d67c762eb77505227a137a737f?s=96&d=mm&r=g","caption":"drtalk"}}]}},"_links":{"self":[{"href":"https:\/\/drtalk.it\/oncology\/wp-json\/wp\/v2\/posts\/935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drtalk.it\/oncology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drtalk.it\/oncology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drtalk.it\/oncology\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/drtalk.it\/oncology\/wp-json\/wp\/v2\/comments?post=935"}],"version-history":[{"count":7,"href":"https:\/\/drtalk.it\/oncology\/wp-json\/wp\/v2\/posts\/935\/revisions"}],"predecessor-version":[{"id":947,"href":"https:\/\/drtalk.it\/oncology\/wp-json\/wp\/v2\/posts\/935\/revisions\/947"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drtalk.it\/oncology\/wp-json\/wp\/v2\/media\/946"}],"wp:attachment":[{"href":"https:\/\/drtalk.it\/oncology\/wp-json\/wp\/v2\/media?parent=935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drtalk.it\/oncology\/wp-json\/wp\/v2\/categories?post=935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drtalk.it\/oncology\/wp-json\/wp\/v2\/tags?post=935"},{"taxonomy":"qtserie","embeddable":true,"href":"https:\/\/drtalk.it\/oncology\/wp-json\/wp\/v2\/qtserie?post=935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}